Zim Laboratories Q2 Results

  • BSE: 541400
  • NSE: ZIMLAB
  • ISIN: INE518E01015
  • Sector: Biotechnology & Drugs
BSE
1072.85 (2.74%)
Volume7.54 K
Updated: Mon 25 Nov, 2024 | 15:11:57
NSE
107.252.52 (2.41%)
Volume96.58 K
Updated: Mon 25 Nov, 2024 | 15:29:06
Today: 105.00
108.25
52-Wk: 89.90
131.30

Q2 Results Highlights

  • Total Income
    ₹92.14 Cr.
    (12.61%)
  • Operating Profit
    ₹4.53 Cr.
    (46.40%)
  • Profit After Tax
    ₹2.38 Cr.
    (165.10%)
  • Operating Margin
    4.92%
    (-19.47%)
Note: Comparison is on YoY basis

Quarterly - Zim Laboratories Q2 Results

*All figures in crores except per share values
Fiscal PeriodSep 24Jun 23QoQ CompSep 23YoY Comp
Total Revenue 92.1467.44-%85.83-%
Selling/ General/ Admin Expenses Total 15.4512.63-%12.83-%
Depreciation/ Amortization 5.004.03-%4.09-%
Other Operating Expenses Total 25.0518.87-%23.76-%
Total Operating Expense 87.6166.64-%80.59-%
Operating Income 4.530.80-%5.24-%
Net Income Before Taxes 2.960.19-%5.44-%
Net Income 2.380.23-%4.15-%
Diluted Normalized EPS 0.490.05-%0.85-%

Recommended For You

    More Recommendations

    Trending Stocks

      Subscribe to Our Newsletter

      Get daily newsletters around different themes from livemint.

      Subscribe
      HomeMarketsPremiumInstant LoanMint Shorts